Congratulations to Dr. Andreas Linder and authors on their recent publication in the journal ‘Gut’. In this study they tested a system based biomarker and prognostic tool (DR-MOMP) for stage III colorectal cancer (CRC). They found that DR- MOMP could be potentially used as a prognostic tool to significantly improve established risk scores for patients with CRC.
See link here